Bricanyl Respules 2.5 mg/ml Nebuliser Solution
Last Updated on eMC 27-Apr-2017 View document | AstraZeneca UK Limited Contact details
Versions
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 27-Apr-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - driving and using machines
- Change to section 5 - how to store or dispose
- Change to section 6 - date of revision
Updated on 02-Jun-2015 and displayed until 27-Apr-2017
Reasons for adding or updating:
- Change to section 1 - what the product is
- Change to section 1 - what the product is used for
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 4 - how to report a side effect
- Change to section 5 - how to store
- Change to section 6 - date of revision
- Improved presentation of PIL
Updated on 26-Nov-2013 and displayed until 02-Jun-2015
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 5 - how to store
- Change to section 6 - date of revision
Updated on 01-Sep-2010 and displayed until 26-Nov-2013
Reasons for adding or updating:
- Correction of spelling/typing errors
Updated on 03-Aug-2010 and displayed until 01-Sep-2010
Reasons for adding or updating:
- Improved Electronic Presentation
Updated on 22-Jan-2010 and displayed until 03-Aug-2010
Reasons for adding or updating:
- Change of trade or generic name
- Change to date of revision
Updated on 08-Apr-2009 and displayed until 22-Jan-2010
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change to side-effects
Updated on 21-Oct-2008 and displayed until 08-Apr-2009
Reasons for adding or updating:
- Change due to user-testing of patient information
Updated on 23-Jul-2004 and displayed until 21-Oct-2008
Reasons for adding or updating:
- Improved Electronic Presentation
Updated on 04-Sep-2002 and displayed until 23-Jul-2004
Reasons for adding or updating:
- Update to PIL
Updated on 14-Sep-2000 and displayed until 04-Sep-2002
Reasons for adding or updating:
- No reasons supplied
AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
+44 (0)1582 838 000
+44 (0)1582 838 003
+44 (0)1582 836 000
0800 783 0033
+44 (0)1582 837 837
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue